Verrica Pharmaceuticals Inc.
VRCAAs of the close on Sep 25, 2026
Price
$4.37
Market cap
—
The cover-page share count does not match the latest report's share count
P/E (diluted TTM)
—
A per-share figure for one of the last four quarters is not shown, so no four-quarter total is given
EPS (TTM)
—
A per-share figure for one of the last four quarters is not shown, so no four-quarter total is given
Dividend yield
—
Dividend records do not yet cover the latest payments
Figures shown here come from public SEC filings. Dates beside each section show the available history.
How Verrica Pharmaceuticals Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 9 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 9, 2026. The latest institutional report shown is dated Sep 30, 2025; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| SPC Financial, Inc. | 2025-06-30 | 30,000 | Not shown | SEC filing |
| Mariner, LLC | 2025-06-30 | 265,295 | Not shown | SEC filing |
| Sovran Advisors, LLC | 2025-06-30 | 750,391 | Not shown | SEC filing |
| IFP Advisors, Inc | 2025-06-30 | 6 | Not shown | SEC filing |
| JONES FINANCIAL COMPANIES LLLP | 2025-06-30 | 73 | Not shown | SEC filing |
| Tower Research Capital LLC (TRC) | 2025-06-30 | 26,886 | Not shown | SEC filing |
| Qube Research & Technologies Ltd | 2025-06-30 | 52,955 | Not shown | SEC filing |
| Point72 Asia (Singapore) Pte. Ltd. | 2025-06-30 | 13,721 | Not shown | SEC filing |
| MORGAN STANLEY | 2025-06-30 | 26,266 | Not shown | SEC filing |
| Creative Planning | 2025-06-30 | 19,083 | Not shown | SEC filing |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 2025-06-30 | 0 | $0 | SEC filing |
| ARMISTICE CAPITAL, LLC | 2025-06-30 | 8,881,344 | Not shown | SEC filing |
| XTX Topco Ltd | 2025-06-30 | 11,063 | Not shown | SEC filing |
| Capital Analysts, LLC | 2025-06-30 | 21,300 | Not shown | SEC filing |
| SteelPeak Wealth, LLC | 2025-06-30 | 76,000 | Not shown | SEC filing |
| STATE STREET CORP | 2025-06-30 | 91,816 | Not shown | SEC filing |
| Legacy Trust | 2025-06-30 | 6,500 | Not shown | SEC filing |
| PNC Financial Services Group, Inc. | 2025-06-30 | 1,031 | Not shown | SEC filing |
- Each value is checked against Verrica Pharmaceuticals Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 17 rows: no share price from within three months of their report dates is on file, so they could not be checked.
- 2 rows left out: the value per share they report is far from Verrica Pharmaceuticals Inc.'s share prices on file from around the report date, far from the value most filers reported for that date, or the value of a security already left out, so they may describe another security or share class.
Filer report history
Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security. Filers with a row left out above, or with no row above to check, are not listed.
- PNC Financial Services Group, Inc.: 4,312 shares reported 2025-03-31; 1,031 shares reported 2025-06-30.
- Legacy Trust: 6,500 shares reported 2025-03-31; 6,500 shares reported 2025-06-30.
- STATE STREET CORP: 567,048 shares reported 2025-03-31; 91,816 shares reported 2025-06-30.
- SteelPeak Wealth, LLC: 76,000 shares reported 2025-03-31; 76,000 shares reported 2025-06-30.
- Capital Analysts, LLC: 16,300 shares reported 2025-03-31; 21,300 shares reported 2025-06-30.
- XTX Topco Ltd: 57,100 shares reported 2025-03-31; 11,063 shares reported 2025-06-30.
- CONCOURSE FINANCIAL GROUP SECURITIES, INC.: 0 shares reported 2025-03-31; 0 shares reported 2025-06-30.
- Creative Planning: 19,018 shares reported 2025-03-31; 19,083 shares reported 2025-06-30.
- MORGAN STANLEY: 69,423 shares reported 2025-03-31; 26,266 shares reported 2025-06-30.
- JONES FINANCIAL COMPANIES LLLP: 73 shares reported 2025-03-31; 73 shares reported 2025-06-30.
- Sovran Advisors, LLC: 392,163 shares reported 2025-03-31; 750,391 shares reported 2025-06-30.
- SPC Financial, Inc.: 30,000 shares reported 2025-03-31; 30,000 shares reported 2025-06-30.
41 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Verrica Pharmaceuticals Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2024-08-26 · Hayes Christopher G.: Larger than 78 of the 83 other insider sales of Common Stock on file. SEC filing
- 2024-08-26 · Bonaccorso Joe: Larger than 75 of the 83 other insider sales of Common Stock on file. SEC filing
- 2024-08-26 · White Ted: Larger than 76 of the 83 other insider sales of Common Stock on file. SEC filing
- 2024-07-22 · White Ted: Larger than 80 of the 83 other insider sales of Common Stock on file. SEC filing
- 2024-07-22 · Bonaccorso Joe: Larger than 77 of the 83 other insider sales of Common Stock on file. SEC filing
- 2023-07-24 · Bonaccorso Joe: Larger than 82 of the 83 other insider sales of Common Stock on file. SEC filing
- 2023-07-24 · Hayes Christopher G.: Larger than 81 of the 83 other insider sales of Common Stock on file. SEC filing
- 2023-07-24 · White Ted: Larger than all 83 other insider sales of Common Stock on file. SEC filing
- 2023-07-24 · Goldenberg Gary: Larger than 79 of the 83 other insider sales of Common Stock on file. SEC filing
Independent insiders buying near the same time
- 2025-11-25–2025-11-25: 6 event(s) across 5 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing )
- 2025-11-25–2025-11-25: 6 event(s) across 5 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing )
- 2024-11-22–2024-11-22: 4 event(s) across 3 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing )
- 2024-11-22–2024-11-22: 4 event(s) across 3 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing )
- 2024-11-22–2024-11-22: 4 event(s) across 3 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing )
- 2021-06-04–2021-06-04: 3 event(s) across 3 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing )
- 2020-08-18–2020-08-25: 4 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing )
- 2020-08-17–2020-08-24: 4 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing )
- 2020-08-13–2020-08-20: 9 event(s) across 4 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing , filing , filing , filing )
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2025-11-25 | Rosenberg Noah L. · CMO | Series C Warrant (right to buy) | P — Open market or private purchase | +589 | unknown | SEC filing |
| 2025-11-25 | Kirby John J. · Interim CFO | Series C Warrant (right to buy) | P — Open market or private purchase | +884 | unknown | SEC filing |
| 2025-11-25 | Kirby John J. · Interim CFO | Common Stock | P — Open market or private purchase | +3,536 | 4.24 | SEC filing |
| 2025-11-25 | Zawitz David · Chief Operating Officer | Common Stock | P — Open market or private purchase | +10,000 | 4.24 | SEC filing |
| 2025-11-25 | Manning Paul B · Director, 10% owner | Common Stock | P — Open market or private purchase | +1,375,380 | 4.24 | SEC filing |
| 2025-11-25 | Rieger Jayson · CEO and President | Common Stock | P — Open market or private purchase | +94,311 | 4.24 | SEC filing |
| 2025-11-25 | Manning Paul B · Director, 10% owner | Common Stock | P — Open market or private purchase | +2,750,762 | 4.24 | SEC filing |
| 2025-11-25 | Zawitz David · Chief Operating Officer | Series C Warrant (right to buy) | P — Open market or private purchase | +2,500 | unknown | SEC filing |
Showing 8 of 20 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-05 | Eichenfield Lawrence · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +16,000 | SEC filing |
| 2026-06-05 | Corcoran Gavin · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +16,000 | SEC filing |
| 2026-06-05 | Rosenberg Noah L. · CMO | Employee Stock Option (right to buy) | A — Grant, award, or other acquisition | +233,840 | SEC filing |
| 2026-06-05 | Nguyen Diem · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +16,000 | SEC filing |
| 2026-06-05 | PRYGOCKI MARK A SR · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +16,000 | SEC filing |
| 2026-06-05 | Rieger Jayson · CEO and President | Employee Stock Option (right to buy) | A — Grant, award, or other acquisition | +512,269 | SEC filing |
| 2026-06-05 | Zawitz David · Chief Operating Officer | Employee Stock Option (right to buy) | A — Grant, award, or other acquisition | +171,340 | SEC filing |
| 2025-12-23 | Kirby John J. · Interim CFO | Common Stock | A — Grant, award, or other acquisition | +10,000 | SEC filing |
Showing 8 of 18 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.